Hepatitis C

CDC Recommends Single-Visit Hepatitis C Testing
 by Emily Harris JAMA July 26, 2023

Analysis: Biden’s Budget Request Emphasizes HIV, HCV Goals
 by Jen Laws HIV/ HCV Update

Biden wants to cure hepatitis C by 2030. These barriers have been standing in the way
 by PBS

2023 Poses Threats and Promises for Public Policy and Patient Advocates
 by Jen Laws HIV/HCV Update

Blame Payers for Only 1:3 Patients Receiving HCV Cure
 by Jen Laws HIV/HCV Watch

DOJ Complaint Flags HCV Drug Denials for People With Addiction
 by Megan Brooks Medscape

Vertical hepatitis C transmission more common than assumed, study finds
 by Caitlyn Stulpin infectious Disease News

Sadly Predictable: STIs & HCV Rates Rising Again
 by Jen Laws HIV/HCV Watch

Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review
 by Camila A. Picchio, Sabela Lens, Manuel Hernandez-Guerr, et al Nature

Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review
 by Camila A. Picchio, Sabela Lens, Manuel Hernandez-Guerr, et al Nature

Fourth Annual State of HCV Care National Survey™ by HealthHCV

Hepatitis C in Black Individuals in the USA Review
 by Oluwaseun Falade-Nwulia, MBBS, MPH. Sharon M. Kelly, PhD, Sasraku Amanor-Boadu, MD, MPH; et al JAMA November 9, 2o23

A National Hepatitis C Elimination Program in the United States. A Historic Opportunity
 by Rachael L. Fleurence, MSc, PhD and Francis S. Collins, MD, PhD JAMA March 9, 2023

Former NIH Director Francis S. Collins on the New White House Plan to Eliminate Hepatitis C
 by Jennifer Abbasi JAMA March 9, 2023

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
 by Polaris Observatory HCV Collaborators Lancet Gastroenterol Hepatol 2022 May;7(5):396-415.

Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis
 by Evan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al Lancet Gastroenterol Hepatol. 2022 May;7(5):426-445.

A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial
 by Sunil S Solomon, Sandra Wagner-Cardoso, Laura Smeaton. et al Lancet Gastroenterol Hepatol. 2022 Apr;7(4):307-317

Boceprevir and telaprevir in the management of hepatitis C virus-infected patients.
 by Butt AA, Kanwal F. Clin Infect Dis. 2012 Jan 1;54(1):96-104

Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver
 Zuckerman E, Safadi R, Oren R, et al Israeli Association for the Study of the Liver.Harefuah. 2012 Dec;151(12):709-14, 719.